Company intelligence / Profile preview
Beijing Taizhou Lize Pharmaceutical Technology
Beijing, Beijing, China
- Ownership
- Private
- Development stage
- Other
01
Overview
Beijing Taizhou Lize Pharmaceutical Technology is a Chinese biotechnology company focused on the research and development of innovative drugs for metabolic diseases. The company primarily targets chronic conditions such as type 2 diabetes and obesity through the development of small molecule therapeutics. Its lead programs include novel GLP-1 receptor agonists and DPP-4 inhibitors designed to improve glycemic control and weight management. Beijing Taizhou Lize operates within the competitive landscape of the Chinese pharmaceutical market, aiming to provide high-quality, affordable treatment options for metabolic health.
- Therapeutic areas
- Endocrinology
- Modalities
- Small molecule
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Beyond the preview
Go deeper on Beijing Taizhou Lize Pharmaceutical Technology.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Beijing Taizhou Lize Pharmaceutical Technology.